BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35803526)

  • 1. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program.
    Kanda Y; Doki N; Kojima M; Kako S; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Atsuta Y; Kodera Y
    Transplant Cell Ther; 2022 Oct; 28(10):677.e1-677.e6. PubMed ID: 35803526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
    Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
    Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
    Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
    Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor.
    Shinzato A; Tabuchi K; Atsuta Y; Inoue M; Inagaki J; Yabe H; Koh K; Kato K; Ohta H; Kigasawa H; Kitoh T; Ogawa A; Takahashi Y; Sasahara Y; Kato S; Adachi S
    Pediatr Blood Cancer; 2013 Sep; 60(9):1513-9. PubMed ID: 23512888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
    Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
    Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
    Connelly-Smith L; Gooley T; Roberts L; Mielcarek M; Linenberger M; Petersdorf E; Sandmaier BM; Milano F
    Transplant Cell Ther; 2023 Nov; 29(11):700.e1-700.e8. PubMed ID: 37659695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.
    Eapen M; Zhang MJ; Tang XY; Lee SJ; Fei MW; Wang HL; Hebert KM; Arora M; Chhabra S; Devine SM; Hamadani M; D'Souza A; Pasquini MC; Phelan R; Rizzo JD; Saber W; Shaw BE; Weisdorf DJ; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):e161-e166. PubMed ID: 32389803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Shimoni A; Niederwieser D; Mufti GJ; Zander AR; Arnold R; Greinix H; Cornelissen JJ; Jackson GH; Craddock C; Bunjes DW; Ganser A; Russell NH; Kyrcz-Krzemien S; Rocha V; Mohty M
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1422-9. PubMed ID: 22446014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
    Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
    Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
    Fernandez-Sojo J; Azqueta C; Valdivia E; Martorell L; Medina-Boronat L; Martínez-Llonch N; Torrents S; Codinach M; Canals C; Elorza I; Parody R; Martino R; Trabazo M; Díaz de Heredia C; Ferra C; Valcárcel D; Linares M; Ancochea Á; García-Rey E; García-Muñoz N; Medina L; Castillo N; Carreras E; Villa J; Querol S
    Bone Marrow Transplant; 2021 Oct; 56(10):2489-2496. PubMed ID: 34127808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience.
    Guo M; Liu J; Clark P; Ahmad S; Patel R; Varela JC; Mori S
    Int J Hematol; 2023 Mar; 117(3):428-437. PubMed ID: 36378406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
    Young JH; Logan BR; Wu J; Wingard JR; Weisdorf DJ; Mudrick C; Knust K; Horowitz MM; Confer DL; Dubberke ER; Pergam SA; Marty FM; Strasfeld LM; Brown JWM; Langston AA; Schuster MG; Kaul DR; Martin SI; Anasetti C;
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):359-370. PubMed ID: 26409243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
    Bankova AK; Caveney J; Yao B; Ramos TL; Bögeholz J; Heydari K; Diaz N; Jackson ML; Lowsky R; Brown JW; Johnston L; Rezvani AR; Frank MJ; Muffly L; Weng WK; Sidana S; Negrin RS; Miklos DB; Shiraz P; Meyer EH; Shizuru JA; Arai S
    Transplant Cell Ther; 2022 Apr; 28(4):215.e1-215.e10. PubMed ID: 35042013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
    Novitzky-Basso I; Remberger M; Chen C; Pasić I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Mattsson J; Michelis FV
    Eur J Haematol; 2022 Jan; 108(1):61-72. PubMed ID: 34606661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen.
    Takahashi S; Ooi J; Tomonari A; Konuma T; Tsukada N; Oiwa-Monna M; Fukuno K; Uchiyama M; Takasugi K; Iseki T; Tojo A; Yamaguchi T; Asano S
    Blood; 2007 Feb; 109(3):1322-30. PubMed ID: 17038536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival.
    Medd P; Nagra S; Hollyman D; Craddock C; Malladi R
    Bone Marrow Transplant; 2013 Feb; 48(2):243-8. PubMed ID: 22732701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation.
    Fuji S; Nakamura F; Hatanaka K; Taniguchi S; Sato M; Mori S; Sakamaki H; Yabe H; Miyamoto T; Kanamori H; Ueda Y; Kawa K; Kato K; Suzuki R; Atsuta Y; Tamaki T; Kanda Y
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1407-14. PubMed ID: 22430086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
    Jo T; Arai Y; Kondo T; Mizuno S; Hirabayashi S; Inamoto Y; Doki N; Fukuda T; Ozawa Y; Katayama Y; Kanda Y; Fukushima K; Matsuoka KI; Takada S; Sawa M; Ashida T; Onizuka M; Ichinohe T; Atsuta Y; Kanda J; Yanada M
    Cytotherapy; 2022 Oct; 24(10):1013-1025. PubMed ID: 35729020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.